Reductively activated disulfide prodrugs of paclitaxel
- PMID: 12443783
- DOI: 10.1016/s0960-894x(02)00784-9
Reductively activated disulfide prodrugs of paclitaxel
Abstract
A series of unsymmetrical polar disulfide prodrugs 2-5 of paclitaxel were designed and synthesized as reductively activated prodrugs. These compounds behaved as prodrugs in vitro on L2987 lung carcinoma cells. In vivo evaluation in mice demonstrated that the mutual prodrug 5 with captopril exhibited significant regressions and cures.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
